BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 319 filers reported holding BIONTECH SE in Q4 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $659,000 | -30.8% | 6,068 | -31.3% | 0.00% | – |
| Q2 2023 | $952,000 | -14.2% | 8,827 | -0.8% | 0.00% | – |
| Q1 2023 | $1,109,000 | -22.8% | 8,901 | -6.9% | 0.00% | – |
| Q4 2022 | $1,436,000 | -9.9% | 9,561 | -19.1% | 0.00% | -100.0% |
| Q3 2022 | $1,593,000 | -11.2% | 11,813 | -1.8% | 0.00% | 0.0% |
| Q2 2022 | $1,794,000 | -55.0% | 12,030 | -48.6% | 0.00% | 0.0% |
| Q1 2022 | $3,990,000 | -54.9% | 23,396 | -31.8% | 0.00% | -50.0% |
| Q4 2021 | $8,847,000 | +20.2% | 34,321 | +27.3% | 0.00% | 0.0% |
| Q3 2021 | $7,359,000 | +4.1% | 26,957 | -14.7% | 0.00% | 0.0% |
| Q2 2021 | $7,072,000 | +435.4% | 31,594 | +161.0% | 0.00% | – |
| Q1 2021 | $1,321,000 | +34.9% | 12,104 | +0.8% | 0.00% | – |
| Q4 2020 | $979,000 | -29.1% | 12,011 | -39.8% | 0.00% | – |
| Q3 2020 | $1,381,000 | +3534.2% | 19,944 | +3315.1% | 0.00% | – |
| Q2 2020 | $38,000 | +153.3% | 584 | +123.8% | 0.00% | – |
| Q1 2020 | $15,000 | +400.0% | 261 | +226.2% | 0.00% | – |
| Q4 2019 | $3,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |